author-photo

Ioannis Lainas

Bristol-Myers Squibb

2

Papers

9

Citations

Citation Trend

Filter By

Papers (2) Sort By

Journal Conference Others

Dasatinib plus SMO antagonist versus dasatinib alone for treating patients (pts) with newly diagnosed Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia in chronic phase (CML-CP): Design of CA180-363, a phase II, open-label randomized trial.

2012 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (5)
A phase II trial of ixabepilone in Asian patients with advanced gastric cancer previously treated with fluoropyrimidine-based chemotherapy

2012 Cancer Chemotherapy and Pharmacology
Show All
- Source
- Cite
- Save
Citations (4)